Stephens Reiterates “Overweight” Rating for Phreesia (NYSE:PHR)

Phreesia (NYSE:PHRGet Free Report)‘s stock had its “overweight” rating restated by analysts at Stephens in a note issued to investors on Friday, Benzinga reports. They currently have a $28.00 target price on the stock. Stephens’ price objective indicates a potential upside of 47.99% from the stock’s previous close.

PHR has been the subject of a number of other research reports. Truist Financial began coverage on Phreesia in a report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a report on Thursday, March 21st. JMP Securities boosted their price objective on Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a report on Thursday, March 21st. Finally, Canaccord Genuity Group boosted their price objective on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a report on Friday, March 15th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Phreesia currently has an average rating of “Moderate Buy” and a consensus target price of $31.38.

View Our Latest Report on Phreesia

Phreesia Stock Performance

Shares of Phreesia stock opened at $18.92 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02. The stock has a 50 day moving average price of $22.55 and a 200-day moving average price of $22.68. Phreesia has a one year low of $12.05 and a one year high of $34.98.

Phreesia (NYSE:PHRGet Free Report) last announced its earnings results on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.16. The firm had revenue of $101.20 million during the quarter, compared to analysts’ expectations of $100.94 million. Phreesia had a negative return on equity of 46.81% and a negative net margin of 31.87%. The company’s quarterly revenue was up 20.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.70) EPS. Equities analysts forecast that Phreesia will post -1.48 EPS for the current year.

Insider Buying and Selling at Phreesia

In other news, COO Evan Roberts sold 25,962 shares of the business’s stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $23.52, for a total value of $610,626.24. Following the completion of the transaction, the chief operating officer now directly owns 728,570 shares of the company’s stock, valued at approximately $17,135,966.40. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, SVP Amy Beth Vanduyn sold 3,354 shares of the business’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $75,867.48. Following the completion of the transaction, the senior vice president now directly owns 123,463 shares of the company’s stock, valued at approximately $2,792,733.06. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Evan Roberts sold 25,962 shares of the business’s stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $23.52, for a total value of $610,626.24. Following the completion of the transaction, the chief operating officer now directly owns 728,570 shares of the company’s stock, valued at $17,135,966.40. The disclosure for this sale can be found here. Insiders sold a total of 82,467 shares of company stock valued at $1,895,776 in the last ninety days. Corporate insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. International Assets Investment Management LLC grew its stake in Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after purchasing an additional 1,411 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Phreesia in the third quarter worth about $53,000. Russell Investments Group Ltd. boosted its stake in shares of Phreesia by 5,462.3% in the fourth quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after buying an additional 3,769 shares during the last quarter. EntryPoint Capital LLC purchased a new stake in shares of Phreesia in the first quarter worth about $169,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Phreesia in the first quarter worth about $202,000. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Featured Stories

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.